简介:企业财务管理信息系统涉及到财务管理、行政和总务等每个方面的工作,同时与企业职工自身的利益密不可分。为了提高企业的工作信息化的水平和实现高等院校自身的管理效率,本文通过对企业财务管理工作中实际出现的问题提出解决的设计思路,将财务管理信息系统和企业信息化系统的内容相结合起来。企业财务管理信息系统更好地辅助学校的各项工作并做出正确的决策。本文通过用户管理模块、账务管理模块、学生收费模块、工资管理模块和员工信息管理模块这五个模块来更好地诠释企业财务管理信息系统的内容,系统采用SQLServer2008、C/S模式、B/S模式的相关技术,描述各系统的功能和信息,使财务管理信息系统更好的应用和服务于企业。
简介:本文介绍了一种以STC12C5A60S2单片机为主控芯心,L298P为电机驱动芯片,通过主控单元产生PWM波控制驱动电路达到控制电机速度的目的。经测试之后发现本系统可以实现电机稳定精确的调速,本装置具有成本低、稳定可靠的特点,具有广泛的应用意义。
简介:摘要静脉血栓栓塞症(VTE)是由遗传和环境因素共同引起的疾病。与欧洲和北美洲人群常见的遗传危险因素不同,亚洲人群VTE的主要遗传危险因素是遗传性抗凝蛋白缺乏。蛋白C和蛋白S均为维生素K依赖的抗凝蛋白,在调节机体凝血功能过程中发挥重要作用。因此,遗传性蛋白C和蛋白S缺乏症相关遗传危险因素的鉴定,对亚洲人群VTE的临床研究具有重要意义。近年来,相关研究已明确部分亚洲人群中遗传性蛋白C和蛋白S缺乏症常见的PROC和PROS1基因突变,并证实其与VTE发生风险增加密切相关。为了提高对VTE的诊治水平,笔者拟就亚洲人群中遗传性蛋白C和蛋白S缺乏症的常见遗传危险因素进行阐述。
简介:摘要目的构建脊柱手术患者结构化3C动态病情观察表格,并探讨其在临床工作中的应用效果。方法基于文献证据综合并通过焦点小组访谈法形成结构化3C病情观察表格。在应用表格前(2018年6—8月)收集100次责任护士用传统表格准备患者病情的相关情况。在应用表格后(2018年9—11月)再次收集100次责任护士用结构化3C病情观察表格准备患者病情的相关情况。比较应用前后护士对患者病情的掌握率、护士掌握患者病情耗时、护士对表格的满意度。结果运用结构化3C病情观察表格后,护士对患者各项病情平均掌握率由88.2%提高到95.1%,差异有统计学意义(χ2=39.826,P<0.01);护士掌握患者病情的耗时由实施前的(7.61±1.67)min缩短到实施后的(5.34±1.33)min,差异有统计学意义(t=10.654,P<0.01);护士对传统表格的满意度评分为(28.50±2.20)分,对结构化3C病情观察表格的满意度评分为(35.80±3.15)分,差异有统计学意义(t=-8.097,P<0.01)。结论运用结构化3C病情观察表格提高了护士对患者病情的掌握率,提高了工作效率,护士对自身护理工作满意度增加,有助于提高护理管理质量。
简介:摘要目的探讨HBV PreC/C及S基因抗原表位的突变对慢性乙型肝炎患者HBeAg血清学状态的影响。方法在横断面研究中,通过纳入35例未经抗病毒治疗慢性乙型肝炎患者,采用巢式PCR-TA克隆-测序方法筛选与HBeAg血清学状态相关的HBV PreC/C和S基因突变位点。然后在纵向研究中(60例)利用多元回归模型校正相关混杂因素,探讨HBV PreC/C及S基因抗原表位的突变与HBeAg状态之间的独立关系。结果在横断面研究中,64.4%的PreC/C突变和68.2%的S突变发生在抗原表位区。有10个突变位点(PreC/C50、55、79、84、103、126、145、184和s110、s213)与HBeAg阴性状态相关(P < 0.05)。在纵向研究中校正了年龄、性别、HBV基因型、血清丙氨酸转氨酶水平和PreC W28*突变等混杂因素后,结果显示Tc细胞表位(PreC47-56、PreC117-125、s208-216)和Th细胞表位(PreC176-185)的突变是影响宿主HBeAg血清学状态的主要独立危险因素。结论HBV PreC/C区(PreC47-56、PreC117-125和PreC176-185)和S区(s208-216)表位的突变是影响宿主HBeAg状态的主要独立因素,提示这些抗原表位的突变可能参与HBeAg的血清学转换。
简介:摘要神经退行性疾病是一类严重危害人类健康的中枢神经系统变性疾病。补体3(C3)-补体3a受体(C3aR)通路是经典补体激活的重要通路之一。大量研究显示C3-C3aR通路可以介导调节星形胶质细胞-小胶质细胞轴相互作用于神经元,导致中枢神经系统功能改变;C3-C3aR通路与阿尔茨海默病、帕金森病、脑卒中、癫痫等神经退行性疾病的发生发展密切相关。本文围绕C3-C3aR通路在几种重要的神经退行性疾病中的研究进展进行综述,旨在讨论C3-C3aR通路在相关神经退行性疾病中的作用,从而为相关疾病的治疗提供一种新的思路。
简介:AbstractThroughout the past 2020, the pandemic COVID-19 has caused a big global shock, meanwhile it brought a great impact on the public health network. Trauma emergency system faced a giant challenge and how to manage trauma under the pandemic of COVID-19 was widely discussed. However, the trauma treatment of special population (geriatric patients and patients taking anticoagulant drugs) has received inadequate attention. Due to the high mortality following severe traumatic hemorrhage, hemostasis and trauma-induced coagulopathy are the important concerns in trauma treatment. Sepsis is another topic should not be ignored when we talking about trauma. COVID-19 itself is a special kind of sepsis, and it may even be called as serious systemic infection syndrome. Sepsis has been become a serious problem waiting to be solved urgently no matter in the fields of trauma, or in intensive care and infection, etc. This article reviewed the research progress in areas including trauma emergency care, trauma bleeding and coagulation, geriatric trauma and basic research of trauma within 2020.
简介:无
简介:摘要目的C型凝集素结构域家族7成员A(CLEC7A)在脑胶质瘤中的表达及临床意义。方法利用基因表达谱数据交互分析(GEPIA)及GlioVis数据库分析CLEC7A在胶质瘤组织中表达水平。通过癌症基因组图谱(TCGA)及中国脑胶质瘤基因图谱计划(CGGA)数据库共收集1 095例胶质瘤样本,用于分析CLEC7A表达与胶质瘤临床病理特征及预后相关性。使用富集分析明确CLEC7A参与的生物学过程。利用单细胞转录组测序数据分析及Spearman相关检验分析CLEC7A表达与胶质瘤免疫浸润的相关性。结果与非肿瘤脑组织相比(Gravendeel:4.247±0.121;Rembrant:5.972±0.400),CLEC7A在胶质瘤组织中显著上调(Gravendeel:5.134±0.577;Rembrant:6.399±0.676),差异有统计学意义(Gravendeel:t=-4.333,P<0.01;Rembrant:t=-3.292,P<0.01)。多因素Cox回归分析显示CLEC7A表达水平是胶质瘤患者预后的独立影响因素[TCGA:风险比(HR):1.637;CGGA:HR:1.678,均P<0.05]。GeneMANIA数据库分析显示CLEC7A与半乳糖凝集素-3(LGALS3)具有强相关性。利用单细胞转录组测序数据(GSE117891)及肿瘤免疫单细胞中心(TISCH)网站分析显示CLEC7A在胶质瘤免疫微环境中胶质瘤相关性小胶质细胞/巨噬细胞(GAMMs)中特异性高表达,并且利用Spearman检验基于TIMER数据进行验证(低级别胶质瘤:R=0.749;高级别胶质瘤:R=0.205,均P<0.01)。结论CLEC7A可能是胶质瘤预后评估及精准治疗的新型标志物。
简介:摘要目的探讨肾小球补体C1q及C3c沉积与糖尿病肾病进展的相关性。方法纳入2011年1月至2019年7月在南京医科大学第一附属医院确诊的2型糖尿病肾病患者112例,其中男性83例(74.1%),年龄(51.22±11.12)岁,随访时间19.0(8.5,31.3)个月。根据肾小球C1q和C3c是否沉积分为四组:C1q无沉积C3c无沉积组(n=38)、C1q无沉积C3c沉积组(n=24)、C1q沉积C3c无沉积组(n=14)和C1q沉积C3c沉积组(n=36),检测24 h尿蛋白等临床指标并收集病理资料。采用Cox回归及Kaplan-Meier生存曲线评估肾C1q和C3c沉积对肾脏预后的影响。结果四组间24 h尿蛋白差异有统计学意义[分别为1.84(0.92,3.89),4.19(2.09,6.50)3.30(1.84,6.70),3.64(2.49,7.22)g/24 h,P<0.01],C1q沉积C3c沉积组24 h尿蛋白定量显著高于C1q无沉积C3c无沉积组(P<0.01)。Kaplan-Meier生存曲线结果提示,四组累积生存率差异有统计学意义(Log-rank χ²=8.785,P<0.05),C1q沉积C3c无沉积组累计生存率最低,预后最差。调整后的多因素Cox分析显示,肾小球C1q和C3c共沉积[风险比(HR)2.260,95%可信区间1.329~3.845,P<0.01]、肾小球C1q+C3c+IgM均沉积(HR=4.142,95%可信区间 1.071~16.021,P<0.05)是肾脏预后的独立危险因素。结论肾小球C1q及C3c沉积与糖尿病肾病患者蛋白尿、较差的肾功能和预后不良相关,且肾小球C1q和C3c共沉积是糖尿病肾病进展的独立危险因素。
简介:摘要目的鉴定1例人类白细胞抗原(human leukocyte antigen,HLA)罕见等位基因C*08:84,并调查该基因的家系遗传情况,预测分析其氨基酸残基改变在编码蛋白分子三维空间结构影响。方法应用单核苷酸序列分析、序列特异性寡核苷酸探针聚合酶链反应及单等位基因组特异性测序确定HLA-C分型并对该基因的先证者进行家系调查。应用Swiss-Model服务器,Phyre2和FATCAT在线软件对其三级结构进行模拟分析,对差异氨基酸结构和所处位置及可能的影响进行推测。结果家系分析表明HLA-C*08:84来自先证者母亲,与同源性最高的HLA-C*08:01相比较存在g.512G>C(p.Trp147Ser)变异。其编码三级结构模拟分析表明氨基酸变异位置为α2链,该位置参与构成抗原多肽结合凹槽F。C*08:84与C*08:01、C*08:02、C*08:03、C*08:22肽结合区182个氨基酸主链分子间抗原结合槽均方根偏差(RMSD)分别为1.70 nm、1.79 nm、0.71 nm、1.70 nm。结论确认并分析了罕见等位基因C*08:84,对其临床意义进行初步探讨和分析。
简介:摘要目的探讨1例Bweak亚型个体的分子机制。方法选取2016年12月5日于浙江省血液中心献血的1例受试者为研究对象。利用血清学方法鉴定受试者的ABO表型,用体外酶活性试验测定其血清中B糖基转移酶(GTB)的活性。用PCR扩增ABO基因第5 ~ 7外显子及侧翼序列并确定其基因型,采用T-A克隆技术分离单倍体并进行测序验证。用ProtParam和PSIPRED软件分析蛋白的一级理化性质和二级结构。用PolyPhen-2、SIFT、PROVEAN三种软件分析错义变异对蛋白的作用效应。结果受试者血清学检测为Bweak亚型,血清中存在抗B抗体。体外酶活性试验显示其GTB活性显著降低。单倍体克隆测序分析发现B等位基因上存在c.398T>C错义变异,为一个新的B等位基因,可导致GTB第133位的苯丙氨酸替换为丝氨酸(p.Phe133Ser)。生物信息学分析提示上述替换对蛋白的一级和二级结构影响不明显,但变异蛋白的热力学能量增加6.07 kcal/mol,严重降低了热稳定性,生物信息学预测该变异对蛋白功能有害。结论新等位基因ABO*B.01-398C是引起Bweak亚型抗原弱表达的机制,生物信息学分析有助于评估其结构和功能的变化。
简介:AbstractBackground:Aberrant activation of the complement system plays an important role in the pathogenesis and development of immunoglobulin A nephropathy (IgAN). The relationship between serum complement and the clinical-histopathological features and outcomes of IgAN is controversial. This retrospective study aimed to examine the relationship between the complement 3/4 (C3/C4) ratio and the clinicopathologic changes and prognosis of patients with IgAN.Methods:A total of 397 patients with primary IgAN from January 2007 to December 2012 at the Chinese People’s Liberation Army General Hospital were included in this study. The correlation test and Chi-square test or one-way analysis of variance test were performed to evaluate the relationship between the C3/C4 ratio and other clinical-pathological factors. Propensity score matching and a multivariate Cox regression model were used to calculate the risk factors of renal outcome.Results:The median follow-up period was 75 months. During the follow-up period, 62 patients (15.6%) developed into the end-stage renal disease (ESRD). The C3/C4 ratio at baseline was associated with the level of serum creatinine (SCr), 24 h urinary protein excretion (24 h Upre), global glomerular sclerosis, and tubulointerstitial lesion. The level of SCr and 24 h Upre and the degree of chronic kidney injury were statistically different among groups defined by different C3/C4 ratio levels. The survival rates of patients among groups with different C3/C4 ratio levels were different. After propensity score matching, eighty-eight pairs of patients were successfully matched, and the C3/C4 ratio was an influencing factor for the patients’ outcome (hazard ratio 0.587, 95% confidence interval 0.329-0.880). Patients with a C3/C4 ratio <3.6 had a poorer outcome compared with the others (P = 0.002).Conclusions:IgAN patients with decreased C3/C4 ratio displayed significantly more severe clinical symptoms and chronic renal injury than patients with higher ratios. A low C3/C4 ratio could be a risk factor for patients developing to ESRD.
简介:AbstractObjectives:To investigate the prevalence of ACADM pathogenic variants, c.985A>G and c.199T>C, for medium chain acyl CoA dehydrogenase deficiency (MCADD) in a healthy population in the southern region of Brazil.Methods:This was an observational cross-sectional study with a convenience sampling strategy. The participants were recruited from the blood bank of the Hospital de Clínicas of Porto Alegre, Brazil. A total of 1000 healthy individuals from the state of Rio Grande do Sul were included. Genotyping for the c.199T>C and c.985A>G variants was performed using real-time polymerase chain reaction (PCR) and the PCR-restriction fragment length polymorphism (RFLP) technique, respectively. Individuals considered heterozygous for c.985A>G were subjected to additional acylcarnitine profile analysis using tandem mass spectrometry. Carrier frequency was obtained by calculating the ratio of heterozygous individuals to the total number of individuals analyzed and reported with a 95% confidence interval. Allele and genotype frequencies were calculated based on the Hardy-Weinberg equilibrium.Results:The c.985A>G variant was detected as heterozygotes in three individuals (frequency of the heterozygous genotype = 1:333, allele frequency= 0.0015, minimum frequency of MCADD= 1:444,444) whose acylcarnitine profiles were within normal limits. The c.199T>C variant was not identified.Conclusions:Considering the small sample size and associated allelic heterogeneity with MCADD, these findings are believed to denote the rarity or underdiagnosis of MCADD in southern Brazil. This study provides evidence for the need for further investigation to ascertain the contribution of these diseases to child morbidity and mortality in the country.